US 9044457
Anti-DR4 agonist antibodies
granted A61KA61K39/3955A61K45/06
Quick answer
US patent 9044457 (Anti-DR4 agonist antibodies) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K39/3955, A61K45/06, A61P, A61P35/00